Table 4.
PND 6 Month | PND 1 Year | |||||
---|---|---|---|---|---|---|
|
|
|||||
Endpoints | Time points | Sex | EE2 | BPA | EE2 | BPA |
% CD80+ cells within NK cells | 24hr | F | ↓0.5 | ↓25000 | N | N |
M | ↑0.5 | ↑2.5 | N | N | ||
| ||||||
48hr | F | N | N | N | N | |
M | N | N | N | N | ||
| ||||||
% CD86+ cells within NK cells | 24hr | F | N | N | N | N |
M | N | ↑25000 | N | ↑25000 | ||
| ||||||
48hr | F | N | N | N | N | |
M | N | N | N | ↑25 |
F: female; M: male. N indicates no significant difference compared to control groups. ↑ indicates increase and ↓ indicates decrease. Numbers designate the dose levels (μg/kg bw/day) at which significant changes were observed.